XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,278,000 | -0.5% | 42,000 | 0.0% | 0.02% | +72.7% |
| Q1 2022 | $1,284,000 | -23.3% | 42,000 | -21.6% | 0.01% | -21.4% |
| Q4 2021 | $1,674,000 | +103.4% | 53,600 | 0.0% | 0.01% | +133.3% |
| Q3 2021 | $823,000 | -50.8% | 53,600 | -64.6% | 0.01% | -84.6% |
| Q3 2020 | $1,674,000 | -11.7% | 151,235 | 0.0% | 0.04% | -31.6% |
| Q2 2020 | $1,896,000 | +10.6% | 151,235 | 0.0% | 0.06% | -28.8% |
| Q1 2020 | $1,715,000 | -13.5% | 151,235 | +0.0% | 0.08% | +40.4% |
| Q4 2019 | $1,982,000 | +46.8% | 151,206 | 0.0% | 0.06% | +9.6% |
| Q3 2019 | $1,350,000 | -8.6% | 151,206 | +1.0% | 0.05% | -16.1% |
| Q2 2019 | $1,477,000 | +1.2% | 149,758 | +4.3% | 0.06% | -7.5% |
| Q1 2019 | $1,459,000 | +136.1% | 143,607 | +46.5% | 0.07% | +148.1% |
| Q4 2018 | $618,000 | – | 98,007 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |